Two principal forms of hexosaminidase are present in human tissues and were first isolated from spleen by Robinson & Stirling (1968) . The acidic form A and the basic form B can be separated by a variety of techniques including ion-exchange chromatography and gel electrophoresis. It has been demonstrated that the A component of serum can be distinguished from the tissue A component of liver by its susceptibility to neuraminidase treatment (Swallow et al., 1974) . The tissue A and serum A" forms can be separated by ion-exchange chromatography (Ikonne & Ellis, 1973) , since the AS form is eluted by a lower molarity of NaCl than the tissue A form. Further minor intermediate forms I1 and Iz are also found in serum (Price &Dance, 1972) and are present in varying amounts in other tissues. Ellis et al. (1975~) demonstrated that the hexosaminidase isoenzyme distribution in urine varied in patients with a range of renal diseases. Loss of kidney hexosaminidase into the urine changed the form-A: form-B ratio and the percentage contribution of form B to the total hexosaminidase activity increased with the severity of the renal lesion. The change in isoenzyme pattern found in this study (Ellis et al., 1 9 7 5~) prompted an investigation of the isoenzyme composition of other body fluids in relation to tissue damage.
In the present study we have compared the hexosaminidase isoenzyme patterns of normal urine, serum and synovial fluid on DEAE-cellulose chromatography with the elution profiles obtained with synovial fluid from rheumatoid arthritics, urine from renal patients and serum from patients with hepatic disease. The relative elution of the tissue A form was determined by using kidney homogenates.
Fresh urine samples were collected without preservatives, and used immediately or stored at 4°C. Blood was collected without coagulant, allowed to clot and serum separated immediately. Synovial fluid was obtained from patients having routine joint aspirations. Kidneys were obtainedpost mortem or as a result of unplaced donor transplants and homogenates (lo%, w/v) were prepared in water by using a smooth glass PotterElvejhem homogenizer (Ellis et al., 1975~) . DEAE-cellulose columns were prepared and used as described previously by Ellis et al. (1975~) . Column fractions were assayed for hexosaminidase activity by the automated fluorimetric method of Tucker et al. (1975) and the sodium content, which was used to measure the NaCl gradient, was determined by flame photometry. The total enzyme activity corresponding to each peak was determined by integrating the area under each peak (Ellis et al., 1975~) . Samples were also analysed by using a rapid automated ion-exchange system based on that described by Ellis et al. (19756) . "aCl] (m) Hexosaminidase activity is expressed in arbitrary units. Serum (2nd) was dialysed against 0.01 M-sodium phosphate buffer, pH7.0, at 4°C for 2h, and 0.4ml was applied to the column.
BIOCHEMICAL SOCIETY TRANSACTIONS
The total hexosaminidase activities in all the pathological samples assayed were increased up to 1 0 times the activities in normal serum, urine and synovial fluid.
The relative amounts of each isoenzyme in kidney homogenates and body fluids were determined by using DEAE-cellulose chromatography. The activities of hexosaminidase isoenzymes in urine, kidney, serum and synovial fluid are compared in Table 1 . The tissue A form is predominant in urine, but the isoenzyme pattern in synovial fluid W~S similar to that of serum.
The hexosaminidase pattern of the pathological samples resembled the tissue pattern seen in the kidney. It can be seen in Fig. 1 that the hexosaminidase pattern found in the serum of a patient with infectious hepatitis differs markedly from the normal serum pattern. There is a pronounced increase in the activity of all the isoenzymes present, particularly the B form, which is normally present in low activities. This change in isoenzyme pattern is remarkably similar to that present in pathological urine. A similar pattern was observed in synovial fluid from arthritics. The presence of the B form therefore appears to be a sensitive indicator of cell damage. In some pathological samples of synovial fluid a second A-form component was present resulting in a double peak. The double peak may be explained by the presence of both the A and the As forms in the same sample. It is worth noting, however, that there are a number of different components present in the A-form peak from leucocytes and amniotic fluid (R. B. Ellis, personal communication). The possibility of the microheterogeneity of the hexosaminidase A form should therefore be considered when interpreting pathological data.
The present findings appear to be of interest in the assessment of tissue damage and in the study of the interrelationships of tissue and body fluid forms of hexosaminidase. Further study may also provide an insight into the mechanisms involved in the secretion of enzymes.
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